Atlas Trials

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients

Clinical trial NCT04111367 · UNKNOWN

Trial details

NCT number
NCT04111367
Sponsor
Ginkgopharma CO., LTD
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C Virus Infection
Start date
2019-04-03
Primary completion
2020-04-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.